Acute Myeloid Leukemia (AML)
AML Webinar Series
Leading experts shared recent breakthroughs in AML treatment and research announced at the 2018 American Society of Hematology (ASH) annual meeting. The panel discusses new drug approvals, emerging clinical trial data and innovative, individualized approaches to treat distinct AML subtypes. How will these advances translate to the real world? Viewers will also learn how these developments will impact AML patients and other promising therapies in the pipeline.